Cargando…
Immunotherapy for Dogs: Still Running Behind Humans
Despite all good intentions, dogs are still running behind humans in effective cancer immunotherapies. The more effective treatments in humans, like infusions of CAR-T and NK-cells are not broadly pursued for canines due to significant costs, the rather complicated logistics and the lack of targetab...
Autor principal: | Klingemann, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374065/ https://www.ncbi.nlm.nih.gov/pubmed/34421888 http://dx.doi.org/10.3389/fimmu.2021.665784 |
Ejemplares similares
-
Immunotherapy for Dogs: Running Behind Humans
por: Klingemann, Hans
Publicado: (2018) -
Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016) -
Cellular Immunotherapy of Canine Cancer
por: Addissie, Selamawit, et al.
Publicado: (2018) -
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
por: Perrino, Matteo, et al.
Publicado: (2023) -
A Role for Dogs in Advancing Cancer Immunotherapy Research
por: Dow, Steven
Publicado: (2020)